Walking on a thin line between potent platelet inhibition for myocardial infarction and risk of hemorrhagic complications. Tirofiban induced subconjunctival hemorrhage

Laurencet, Marie-Eva; Iglesias, Juan; Noble, Stéphane Laurent; Tessitore, Elena; Degrauwe, Sophie

doi:10.5603/CJ.2021.0032

Scientific article

Case report

English

Walking on a thin line between potent platelet inhibition for myocardial infarction and risk of hemorrhagic complications. Tirofiban induced subconjunctival hemorrhage

ContributorsLaurencet, Marie-Eva; Iglesias, Juan; Noble, Stéphane Laurent

; Tessitore, Elena; Degrauwe, Sophie

Published inCardiology Journal, vol. 28, no. 2, p. 351-352

Publication date2021

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Citation (ISO format)

LAURENCET, Marie-Eva et al. Walking on a thin line between potent platelet inhibition for myocardial infarction and risk of hemorrhagic complications. Tirofiban induced subconjunctival hemorrhage. In: Cardiology Journal, 2021, vol. 28, n° 2, p. 351–352. doi: 10.5603/CJ.2021.0032

Article (Published version)

CC BY-NC-ND

Identifiers

PID : unige:151707
DOI : 10.5603/CJ.2021.0032
PMID : 33881772

Additional URL for this publicationhttps://journals.viamedica.pl/cardiology_journal/article/view/72439

Journal ISSN1898-018X

188views

101downloads

Creation06/05/2021 10:28:00

First validation06/05/2021 10:28:00

Update16/03/2023 00:35:34

Status update16/03/2023 00:35:33

Last indexation31/10/2024 22:06:51

Archive ouverte UNIGE

Walking on a thin line between potent platelet inhibition for myocardial infarction and risk of hemorrhagic complications. Tirofiban induced subconjunctival hemorrhage

Technical informations